Lidocaine gel (Centrexion Therapeutics)

利多卡因凝胶 (Centrexion Therapeutics)

Report date: 2025/10/27 17:54:58

Base Information

Drug NameLidocaine gel (Centrexion Therapeutics)
Drug Alias NameCNTX-2022
ClassificationSmall molecules
Mechanisms of ActionSodium channel alpha subunit modulators
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPainOsteoarthritis, KneeHerpes Zoster
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCentrexion Therapeutics Corp
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsOsteoarthritis, KneeHerpes Zoster

Other Information

ATC CodeN/A